<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The presence of <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) in patients with large <z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e> (PE) is associated with an increased risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Many patients are ineligible to receive thrombolytic therapy </plain></SENT>
<SENT sid="2" pm="."><plain>We present a patient with bilateral PE and cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> who was treated effectively with rheolytic thrombectomy with AngioJet, <z:mp ids='MP_0004225'>PFO</z:mp> closure with CardioSeal device, and placement of an inferior vena cava filter </plain></SENT>
</text></document>